Boston Life Sciences

Boston Life Sciences, Inc (NASDAQ: BLSI) is a biotechnology company engaged in the research and development of biopharmaceutical products for the diagnosis and treatment of Central Nervous System disorders. Our energy and focus in this area are reflected in several important initiatives. Our molecular imaging program has a product candidate, the ALTROPANE® molecular imaging agent, in phase 3 clinical development. ALTROPANE® is a diagnostic tool intended to aid in differentiating Parkinsonian tremors from non-Parkinsonian or Essential Tremor. ALTROPANE is also being assessed in Phase II trials for diagnosing ADHD. Through our licensing and research collaboration with Children's Hospital Boston, Boston Life Sciences maintains a world-class position in the field of regenerating nerve axons. Our sponsored scientific research in this ground-breaking technology may someday make possible therapies leading to functional recovery following stroke, spinal cord and ocular injuries. Finally, our program in Parkinson’s Disease aims to provide a therapeutic solution to managing the symptoms as well as to slowing the progression of the disease.

Contact Details: 85 Main Street Hopkinton 01748 United States of America Tel: (508) 497-2360 Fax: (508) 497-9964 Email: IR@bostonlifesciences.com WWW: www.bostonlifesciences.com/

BioNews Results for Boston Life Sciences:
ViroPharma to Present at Three September Healthcare Conferences	Montana's News Station:  Aug 31 2008 2:04PM Matching: boston life sciences
ViroPharma to Present at Three September Healthcare Conferences	KSLA:  Aug 30 2008 3:44PM Matching: boston life sciences
Cubist Pharmaceuticals to Present at September Investor Conferences	SmartBrief:  Aug 30 2008 11:57AM Matching: boston life sciences
ViroPharma to Present at Three September Healthcare Conferences	KRON4:  Aug 30 2008 11:17AM Matching: boston life sciences
ViroPharma to Present at Three September Healthcare Conferences	KOTA Territory News:  Aug 30 2008 4:40AM Matching: boston life sciences
Promote your company here: BioNewsCast - Press Release Distribution	→View more Boston Life Sciences news.

Boston Life Sciences Patents:
US Patent No.	Title
7078385	Methods of inhibiting angiogenesis with fragments and homologs of troponin subunit I
6586401	Troponin subunit I fragment and homologs thereof
6465431	Pharmaceutical compositions comprising troponin subunits, fragments and homologs thereof and methods of their use to inhibit angiogenesis

Boston Life Sciences (BLSI) Financial information Links from Barchart
BLSI Quote from from Barchart.com
BLSI Chart from from Barchart.com
BLSI Profile from from Barchart.com
BLSI Opinion from from Barchart.com
→View more Boston Life Sciences finance information.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 466 times since April 2007, the link to the organisation's website has been followed 82 times

Recent Search Terms used to find this page: Altropane adhd phase 3 | what is boston life science | boston life science drug discovery | life science Boston | boston life | .

Search for more companies in Hopkinton

Search for more companies in

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Boston Life Sciences